Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Action Potential Venture Capital (APVC) is a venture capital firm founded in 2016 and based in the United States. The firm focuses on early-stage investments in healthcare technology, particularly in digital health, therapeutics, and medical devices. APVC is backed by GSK, enhancing its credibility in the healthcare sector.
APVC invests in pre-seed, seed, and seed-plus stages, targeting companies that develop technologies aimed at improving health outcomes. Their investment thesis emphasizes the intersection of healthcare and technology, with a keen interest in digital health solutions, therapeutics, and medical devices.
David M. Stout - Partner, with extensive experience in healthcare investments. Jennifer A. Dyer - Partner, focused on digital health and therapeutics. Michael J. McGinnis - Partner, specializing in medical devices and health technology.
Submit through their form at actionpotentialvc.com.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.